Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

BACKGROUND: Metastatic breast cancer (MBC) prognosis is highly variable, depending on various factors such as the biological subtype, the performance status, disease extension…. A better evaluation of a patient’s prognostic factors could allow for a more accurate choice of treatments. The role of se...

Descripción completa

Detalles Bibliográficos
Autores principales: Darlix, Amélie, Lamy, Pierre-Jean, Lopez-Crapez, Evelyne, Braccini, Antoine Laurent, Firmin, Nelly, Romieu, Gilles, Thezenas, Simon, Jacot, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937557/
https://www.ncbi.nlm.nih.gov/pubmed/27387327
http://dx.doi.org/10.1186/s12885-016-2448-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937557/
https://www.ncbi.nlm.nih.gov/pubmed/27387327
http://dx.doi.org/10.1186/s12885-016-2448-1

Ejemplares similares